Placebo (for Semuloparin sodium)

DRUG2 trials

Sponsors

Sanofi

Conditions

Venous Thromboembolism

Phase 2

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery

CompletedNCT00331838

SanofiVenous Thromboembolism

Start: 2006-05-31End: 2007-06-30Updated: 2013-01-15

Phase 3

Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery

CompletedNCT00709904

SanofiVenous Thromboembolism

Start: 2008-06-30End: 2010-01-31Updated: 2013-06-14